Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium.
作者： Marc Raes , Danielle Strens , Anne Vergison , Marc Verghote , Baudouin Standaert
DOI: 10.1097/INF.0B013E318214B811
关键词:
摘要: Background:This study investigated the effect of pediatric vaccination against rotavirus on number rotavirus-related hospitalizations children in Belgium.Methods:This retrospective database was conducted at 12 hospitals Belgium (546 beds, 30.6% Belgian total
ulb.ac.be
lww.com 
sci-hub.se 参考文章(19)
Stephen B Lambert, Cassandra E Faux, Lisa Hall, Frances A Birrell, Karen V Peterson, Christine E Selvey, Theo P Sloots, Michael D Nissen, Keith Grimwood, Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland The Medical Journal of Australia. ,vol. 191, pp. 157- 160 ,(2009) , 10.5694/J.1326-5377.2009.TB02727.X
Timo Vesikari, Aino Karvonen, Leena Puustinen, Shang-Qin Zeng, Evelyn Dora Szakal, Andrée Delem, Beatrice De Vos, Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants Pediatric Infectious Disease Journal. ,vol. 23, pp. 937- 943 ,(2004) , 10.1097/01.INF.0000141722.10130.50
F Gimenez-Sanchez, A Delgado-Rubio, F Martinon-Torres, E Bernaola-Iturbe, , Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain. Acta Paediatrica. ,vol. 99, pp. 738- 742 ,(2010) , 10.1111/J.1651-2227.2010.01684.X
A Fruytier, J Van Schoor, B Standaert, PIH3 VACCINATION WITH RIX4414 IS COST-EFFECTIVE IN A BELGIAN SETTING Value in Health. ,vol. 9, ,(2006) , 10.1016/S1098-3015(10)63361-X
A. Martin, A. Batty, J.A. Roberts, B. Standaert, Cost-effectiveness of infant vaccination with RIX4414 (Rotarix™) in the UK Vaccine. ,vol. 27, pp. 4520- 4528 ,(2009) , 10.1016/J.VACCINE.2009.05.006
Maria Paulke-Korinek, Pamela Rendi-Wagner, Michael Kundi, Renate Kronik, Herwig Kollaritsch, Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatric Infectious Disease Journal. ,vol. 29, pp. 319- 323 ,(2009) , 10.1097/INF.0B013E3181C18434
Christina Atchison, Ben Lopman, William John Edmunds, None, Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales Vaccine. ,vol. 28, pp. 3118- 3126 ,(2010) , 10.1016/J.VACCINE.2010.02.060
Baudouin Standaert, Olof Harlin, Ulrich Desselberger, The Financial Burden of Rotavirus Disease in Four Countries of the European Union Pediatric Infectious Disease Journal. ,vol. 27, ,(2008) , 10.1097/INF.0B013E31815EEE1A
T Vesikari, A Karvonen, R Prymula, V Schuster, JC Tejedor, and Investigators ( Aristegui J), None, Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study The Lancet. ,vol. 370, pp. 1757- 1763 ,(2007) , 10.1016/S0140-6736(07)61744-9
Mark Zeller, Mustafizur Rahman, Elisabeth Heylen, Sarah De Coster, Sofie De Vos, Ingrid Arijs, Luis Novo, Natasha Verstappen, Marc Van Ranst, Jelle Matthijnssens, Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium Vaccine. ,vol. 28, pp. 7507- 7513 ,(2010) , 10.1016/J.VACCINE.2010.09.004